For example, Wichmann et al. investigated a comparable HNSCC cohort (n = 90) and reported HLA-B*13, HLA-B*35, and HLA-B*51 as independent predictors of PFS in HNSCCs [12,22]. This evidence concerns the gene HLA-B and head and neck squamous cell carcinoma.